Agios Pharmaceuticals, Inc. (AGIO) Balance Sheet
AGIO balance sheet, 2025
December 31, 2025 · U.S. dollars$1.30B assets = $104.1M liabilities + $1.19B equity
Both columns are drawn to the same scale: what AGIO owns equals what it owes plus shareholders’ equity. Hover a block for its value.
AGIO financial health
Descriptive bands, not a rating. Fiscal 2025.
AGIO balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $619.1M2016 | $1.30B2025 | +8.6%/yr | |
| Total liabilities | $260.5M2016 | $104.1M2025 | −9.7%/yr | |
| Shareholders’ equity | $358.6M2016 | $1.19B2025 | +14.3%/yr | |
| Cash & short-term investments | $573.6M2016 | $854.4M2025 | +4.5%/yr | |
| Total debt | $154.3M2016 | $40.2M2025 | −13.9%/yr | |
| Net cash (debt) | $419.3M2016 | $814.2M2025 | +$395.0M | |
| Working capital | $471.5M2016 | $859.8M2025 | +$388.4M | |
| Book value per share | $9.162016 | $20.582025 | +9.4%/yr | |
| Debt / equity | 0.432016 | 0.032025 | −0.40 | |
| Shares outstanding | 39.1M2016 | 58.0M2025 | +4.5%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
AGIO assets
AGIO liabilities and equity
AGIO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
AGIO balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $854.4M | $893.7M | $776.9M | $783.1M | $1.02B | $572.9M | $564.9M | $805.4M | $567.8M | $573.6M |
| Cash & equivalents | $89.1M | $76.2M | $88.2M | $139.3M | $203.1M | $127.4M | $80.9M | $805.4M | $567.8M | $573.6M |
| Short-term investments | $765.3M | $817.5M | $688.7M | $643.9M | $816.9M | $445.5M | $483.9M | $514.8M | $321.2M | $380.6M |
| Receivables | $10.6M | $4.1M | $2.8M | $2.2M | $4.4M | $25.4M | $15.3M | $10.4M | $3.8M | $8.3M |
| Inventory | $32.9M | $27.6M | $19.1M | $8.5M | $16.2M | $14.7M | $7.3M | $869,000 | −$143.8M | −$32.2M |
| Other current assets | $44.1M | $40.2M | $35.0M | $39.0M | $23.6M | $23.7M | $24.2M | $0 | $17.5M | $10.3M |
| Total current assets | $942.1M | $965.6M | $833.8M | $832.8M | $1.06B | $636.7M | $611.7M | $613.8M | $445.3M | $559.9M |
| Property, plant & equipment (net) | $41.2M | $54.6M | $69.8M | $88.1M | $104.2M | $116.1M | $126.1M | $24.3M | $24.4M | $25.3M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $310.0M | $638.3M | $29.4M | $313.9M | $266.4M | $97.6M | $152.9M | $220.1M | $143.8M | $32.2M |
| Other non-current assets | $3.9M | $4.7M | $4.1M | $4.0M | $2.9M | $2.6M | $0 | $238,000 | $891,000 | $1.6M |
| Total assets | $1.30B | $1.66B | $937.1M | $1.24B | $1.44B | $853.0M | $890.7M | $858.5M | $614.4M | $619.1M |
| Liabilities | ||||||||||
| Accounts payable | $18.4M | $16.6M | $9.8M | $18.6M | $16.7M | $17.7M | $21.9M | $17.9M | $22.8M | $17.1M |
| Short-term debt | $18.4M | $16.8M | $15.0M | $13.7M | $11.2M | $7.4M | $6.9M | $59.8M | $125.8M | $154.3M |
| Deferred revenue | — | −$16.8M | — | — | — | — | $10.9M | $92.5M | $163.6M | $190.2M |
| Total current liabilities | $82.2M | $81.2M | $68.0M | $62.6M | $59.8M | $94.4M | $92.9M | $93.5M | $94.9M | $88.4M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $673,000 | $0 | $0 | $0 |
| Lease obligations | $40.2M | $57.0M | $72.0M | $85.7M | $97.1M | $105.2M | $113.7M | — | — | — |
| Other long-term liabilities | $21.9M | $41.1M | $58.1M | $75.3M | $85.9M | $359.1M | $156.7M | $77.4M | $144.0M | $172.1M |
| Total liabilities | $104.1M | $122.2M | $126.1M | $137.9M | $145.8M | $453.5M | $250.2M | $170.9M | $238.9M | $260.5M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $75,000 | $73,000 | $72,000 | $71,000 | $71,000 | $69,000 | $68,000 | $58,000 | $49,000 | $42,000 |
| Retained earnings (deficit) | −$561.7M | −$148.9M | −$822.6M | −$470.6M | −$238.8M | −$1.84B | −$1.52B | −$1.10B | −$798.1M | −$483.2M |
| Treasury stock | — | — | — | −$802.5M | −$802.5M | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | $2.2M | −$1.5M | −$441,000 | −$12.5M | −$1.2M | $105,000 | $202,000 | −$2.2M | −$1.4M | −$313,000 |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $1.19B | $1.54B | $811.0M | $1.10B | $1.29B | $399.5M | $640.5M | $687.5M | $375.5M | $358.6M |
| Key figures | ||||||||||
| Total debt | $40.2M | $57.0M | $72.0M | $85.7M | $97.1M | $105.2M | $113.7M | $59.8M | $125.8M | $154.3M |
| Net cash (debt) | $814.2M | $836.7M | $704.9M | $697.5M | $922.9M | $467.7M | $451.2M | $745.6M | $442.0M | $419.3M |
| Working capital | $859.8M | $884.4M | $765.9M | $770.1M | $1.00B | $542.3M | $518.8M | $520.3M | $350.3M | $471.5M |
| Tangible book value | $1.19B | $1.54B | $811.0M | $1.10B | $1.29B | $399.5M | $640.5M | $687.5M | $375.5M | $358.6M |
| Book value per share | $20.58 | $26.62 | $14.57 | $20.09 | $21.37 | $5.79 | $10.68 | $11.97 | $8.06 | $9.16 |
| Shares outstanding | 58.0M | 57.9M | 55.7M | 54.8M | 60.4M | 69.0M | 60.0M | 57.4M | 46.6M | 39.1M |
| Current ratio | 11.46 | 11.90 | 12.27 | 13.30 | 17.79 | 6.74 | 6.59 | 6.56 | 4.69 | 6.33 |
| Quick ratio | 10.52 | 11.06 | 11.47 | 12.54 | 17.12 | 6.34 | 6.25 | 8.73 | 6.02 | 6.58 |
| Debt / equity | 0.03 | 0.04 | 0.09 | 0.08 | 0.08 | 0.26 | 0.18 | 0.09 | 0.34 | 0.43 |
| Equity / assets | 92.0% | 92.7% | 86.5% | 88.9% | 89.9% | 46.8% | 71.9% | 80.1% | 61.1% | 57.9% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $617.6M | $737.0M | $854.4M | $952.9M | $938.9M | $893.4M | $893.7M | $1.00B | $569.9M | $598.0M | $776.9M | $647.5M |
| Cash & equivalents | $99.6M | $113.6M | $89.1M | $92.7M | $80.9M | $79.0M | $76.2M | $253.7M | $84.5M | $118.8M | $88.2M | $64.3M |
| Short-term investments | $517.9M | $623.4M | $765.3M | $860.1M | $858.1M | $814.4M | $817.5M | $751.0M | $485.4M | $479.2M | $688.7M | $583.2M |
| Receivables | $20.1M | $16.1M | $10.6M | $5.0M | $5.0M | $3.3M | $4.1M | $3.1M | $3.8M | $3.5M | $2.8M | $1.2M |
| Inventory | $30.2M | $35.1M | $32.9M | $32.0M | $30.8M | $29.6M | $27.6M | $26.4M | $23.9M | $23.1M | $19.1M | $17.3M |
| Other current assets | $49.8M | $46.6M | $44.1M | $43.2M | $44.7M | $42.3M | $40.2M | $39.9M | $34.5M | $39.1M | $35.0M | $38.4M |
| Total current assets | $717.7M | $834.8M | $942.1M | $1.03B | $1.02B | $968.6M | $965.6M | $1.07B | $632.1M | $663.6M | $833.8M | $704.4M |
| Property, plant & equipment (net) | $9.9M | $37.8M | $41.2M | $44.3M | $47.4M | $50.9M | $54.6M | $57.7M | $61.5M | $65.7M | $69.8M | $73.9M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $347.3M | $0 | $310.0M | $304.3M | $400.5M | $531.3M | $638.3M | $655.9M | $75.4M | $116.3M | $29.4M | $224.9M |
| Other non-current assets | $33.6M | $312.4M | $3.9M | $3.9M | $3.9M | $4.7M | $4.7M | $4.1M | $4.1M | $4.1M | $4.1M | $4.1M |
| Total assets | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773.1M | $849.7M | $937.1M | $1.01B |
| Liabilities | ||||||||||||
| Accounts payable | $16.3M | $13.7M | $18.4M | $19.6M | $17.5M | $13.7M | $16.6M | $17.1M | $10.0M | $11.2M | $9.8M | $13.3M |
| Short-term debt | $19.2M | $18.8M | $18.4M | $18.0M | $17.6M | $17.2M | $16.8M | $16.3M | $15.9M | $15.4M | $15.0M | $14.7M |
| Deferred revenue | — | — | — | — | — | — | — | $52.7M | — | — | — | — |
| Total current liabilities | $70.2M | $58.8M | $82.2M | $74.8M | $70.4M | $52.4M | $81.2M | $119.5M | $62.6M | $51.7M | $68.0M | $58.4M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $31.2M | $35.7M | $40.2M | $44.5M | $48.8M | $52.9M | $57.0M | $60.8M | $64.6M | $68.3M | $72.0M | $75.5M |
| Other long-term liabilities | $12.2M | $17.0M | $21.9M | $26.6M | $31.3M | $36.6M | $41.1M | $45.7M | $49.9M | $54.1M | $58.1M | $62.0M |
| Total liabilities | $82.4M | $75.9M | $104.1M | $101.4M | $101.7M | $89.0M | $122.2M | $165.1M | $112.6M | $105.8M | $126.1M | $120.4M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $76,000 | $76,000 | $75,000 | $74,000 | $74,000 | $74,000 | $73,000 | $73,000 | $73,000 | $73,000 | $72,000 | $72,000 |
| Retained earnings (deficit) | −$761.5M | −$660.8M | −$561.7M | −$453.7M | −$350.2M | −$238.2M | −$148.9M | −$52.4M | −$1.00B | −$904.2M | −$822.6M | −$726.7M |
| Accumulated other comprehensive income | −$1.8M | −$314,000 | $2.2M | $2.1M | $655,000 | $365,000 | −$1.5M | $3.4M | −$1.0M | −$1.1M | −$441,000 | −$5.9M |
| Total shareholders' equity | $1.03B | $1.11B | $1.19B | $1.28B | $1.37B | $1.47B | $1.54B | $1.63B | $660.5M | $743.9M | $811.0M | $886.8M |
| Key figures | ||||||||||||
| Total debt | $31.2M | $35.7M | $40.2M | $44.5M | $48.8M | $52.9M | $57.0M | $60.8M | $64.6M | $68.3M | $72.0M | $75.5M |
| Net cash (debt) | $586.4M | $701.3M | $814.2M | $908.3M | $890.2M | $840.4M | $836.7M | $943.9M | $505.3M | $529.6M | $704.9M | $572.0M |
| Working capital | $647.5M | $776.0M | $859.8M | $958.4M | $949.1M | $916.2M | $884.4M | $954.7M | $569.5M | $611.9M | $765.9M | $645.9M |
| Tangible book value | $1.03B | $1.11B | $1.19B | $1.28B | $1.37B | $1.47B | $1.54B | $1.63B | $660.5M | $743.9M | $811.0M | $886.8M |
| Book value per share | $17.25 | $18.87 | $20.45 | $22.09 | $23.64 | $25.52 | $26.96 | $27.84 | $11.63 | $13.19 | $14.51 | $15.89 |
| Shares outstanding | 59.5M | 58.8M | 58.3M | 58.1M | 57.9M | 57.5M | 57.2M | 58.4M | 56.8M | 56.4M | 55.9M | 55.8M |
| Current ratio | 10.22 | 14.19 | 11.46 | 13.82 | 14.48 | 18.50 | 11.90 | 8.99 | 10.09 | 12.84 | 12.27 | 12.06 |
| Quick ratio | 9.08 | 12.80 | 10.52 | 12.81 | 13.41 | 17.12 | 11.06 | 8.44 | 9.16 | 11.64 | 11.47 | 11.10 |
| Debt / equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.10 | 0.09 | 0.09 | 0.09 |
| Equity / assets | 92.6% | 93.6% | 92.0% | 92.7% | 93.1% | 94.3% | 92.7% | 90.8% | 85.4% | 87.6% | 86.5% | 88.0% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 12, 2026); data from EODHD.
AGIO financial position
At the end of fiscal 2025 (December 31, 2025), Agios Pharmaceuticals had total assets of $1.3 billion (down 22.0% from a year earlier), total liabilities of $104.1 million and shareholders' equity of $1.2 billion. It held $854.4 million in cash and short-term investments against $40.2 million of debt, a net cash position of $814.2 million. Its current ratio was 11.46. In the latest quarter (ended June 30, 2026) total assets were $1.1 billion and equity $1.0 billion.
Related: AGIO income statement, AGIO cash flow statement, AGIO key metrics. See the AGIO stock overview for the latest quote and news.
AGIO balance sheet FAQ
What are Agios Pharmaceuticals's total assets?
Agios Pharmaceuticals reported total assets of $1.3 billion at the end of fiscal 2025 (December 31, 2025), compared with $1.7 billion a year earlier.
How much debt does Agios Pharmaceuticals have?
Agios Pharmaceuticals had $40.2 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.03.
How much cash does Agios Pharmaceuticals have?
Agios Pharmaceuticals held $854.4 million in cash and short-term investments at the end of fiscal 2025; with $40.2 million of debt that is net cash of $814.2 million.
What is Agios Pharmaceuticals's book value?
Agios Pharmaceuticals's shareholders' equity (book value) was $1.2 billion at the end of fiscal 2025, or $20.58 per share.
What is Agios Pharmaceuticals's current ratio?
Agios Pharmaceuticals had current assets of $942.1 million and current liabilities of $82.2 million, a current ratio of 11.46 (it can cover its short-term obligations).